Dendritic cell tumor fusions as a novel tumor vaccine: A phase I trial for patients with metastatic breast cancer.

被引：0
|
作者：
Avigan, D
Gong, JL
Uhl, L
Wu, ZK
Vasir, D
Smith, T
Borges, V
Atkins, M
Stone, C
Giallombardo, N
Schadt, K
Tetreault, JC
Kufe, D
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
45
引用
收藏
页码：14A / 14A
页数：1
相关论文
共 50 条
  • [41] Tumor cell emboli in the lung and transcriptional profiles of circulating tumor cells derived from different vascular compartments in patients with metastatic breast cancer.
    Peeters, D. J.
    Van den Eynden, G. G.
    Rutten, A.
    Onstenk, W.
    Sieuwerts, A. M.
    De laere, B.
    van Dam, P. A.
    Peeters, M.
    Pauwels, P.
    Van Laere, S. J.
    Vermeulen, P. B.
    Dirix, L. Y.
    CANCER RESEARCH, 2012, 72
  • [42] Phase I clinical trial of cancer vaccine with five novel epitope peptides for patients with metastatic colorectal cancer (mCRC).
    Hazama, S.
    Oka, M.
    Yoshida, K.
    Tsunoda, T.
    Yoshino, S.
    Hinoda, Y.
    Nakamura, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Dendritic cell-tumor cell hybrid vaccination for metastatic cancer
    Barbuto, JAM
    Ensina, LFC
    Neves, AR
    Bergami-Santos, PC
    Leite, KRM
    Marques, R
    Costa, F
    Martins, SC
    Camara-Lopes, LH
    Buzaid, AC
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (12) : 1111 - 1118
  • [44] Tumor imaging with the estrogen receptor radioligand Z-[I-123]MIVE in patients with metastatic breast cancer.
    Rijks, LJM
    Bakker, PJM
    Veenhof, CHN
    Boer, GJ
    deBruin, K
    Janssen, AGM
    vanRoyen, EA
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (10) : 1835 - 1835
  • [45] Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer
    Kao, JY
    Zhang, M
    Chen, CM
    Chen, JJ
    IMMUNOLOGY LETTERS, 2005, 101 (02) : 154 - 159
  • [46] A pilot clinical trial of immunotherapy with dendritic cells pulsed with tumor lysates in patients with advanced cancer.
    Bueso, P
    Mayordomo, J
    Cajal, R
    Lasierra, P
    Isla, D
    Blasco, C
    Fuertes, M
    Palomera, L
    Larrad, L
    Tres, A
    ANNALS OF ONCOLOGY, 2000, 11 : 42 - 42
  • [47] The primary clinical trial of dendritic cell vaccine pulsed with apoptosis tumor cell in patients with malignant cancers
    Qian, K.
    Wang, Y.
    Shi, H.
    Wang, G. Yajun
    Ye, Heng
    Min, Haiyan
    Lu, Xiao
    Ning, Yongling
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Phase II Trial of Brostallicin and Cisplatin in Patients with Metastatic Triple Negative Breast Cancer.
    Moreno-Aspitia, A.
    Rowland, K. M.
    Liu, H.
    Hillman, D. W.
    Stella, P. J.
    Perez, E. A.
    CANCER RESEARCH, 2011, 71
  • [49] Phase I study of ifosfamide/doxorubicin in metastatic breast cancer.
    Aziz, Z
    Sana, S
    Sherazi, J
    Ilyas, N
    ANNALS OF ONCOLOGY, 2000, 11 : 36 - 36
  • [50] Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors
    Herbert, Garth S.
    Vreeland, Timothy J.
    Clifton, Guy T.
    Greene, Julia M.
    Jackson, Doreen O.
    Hardin, Mark O.
    Hale, Diane F.
    Berry, John S.
    Nichol, Pauline
    Yin, Sook
    Yu, Xianzhong
    Wagner, Thomas E.
    Peoples, George E.
    VACCINE, 2018, 36 (23) : 3247 - 3253
12345